{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:21:30Z","timestamp":1791699690395,"version":"4.3.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1097\/bor.0000000000000233","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:33:24Z","timestamp":1448382804000},"page":"8-14","source":"Crossref","is-referenced-by-count":22,"title":["Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis."],"prefix":"10.1097","volume":"28","author":[{"given":"Cees G.M.","family":"Kallenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegeners granulomatosis.","volume":"i","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegeners granulomatosis autoantibodies identify a novel DFP-binding protein in the lysosomes of normal human neutrophils.","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(92)90202-M","article-title":"Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.","volume":"93","author":"Kallenberg","year":"1992","journal-title":"Am J Med"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA).","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Path"},{"issue":"suppl 1","key":"R6-4-20210128","first-page":"8","article-title":"A historical essay on detection of antineutrophil cytopasmic antibodies.","volume":"30","author":"Rasmussen","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002810100076","article-title":"Methods for the detection of antineutrophil cytoplasmic antibodies.","volume":"23","author":"Wiik","year":"2001","journal-title":"Springer Semin Immunopathol"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1309\/AJCPG02FGQVAUSIU","article-title":"A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.","volume":"142","author":"Lui","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"762874doi","DOI":"10.1155\/2012\/762874","article-title":"Automatic reading of ANCA-slides: evaluation of the AKLIDES system.","volume":"2012","author":"Damoiseaux","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrrheum.2014.78","article-title":"Current and emerging techniques for ANCA detection in vasculitis.","volume":"10","author":"Csernok","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"R271","DOI":"10.1186\/ar4119","article-title":"Automated interpretation of ANCA patterns: a new approach in the serology of ANCA-associated vasculitis.","volume":"14","author":"Knutter","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12026-014-8588-y","article-title":"A fully automated IFF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.","volume":"61","author":"Shovman","year":"2015","journal-title":"Immunol Res"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3899\/jrheum.140941","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and proteinase 3-ANCA without immunofluorescent ANCA found by routine clinical testing.","volume":"42","author":"Rao","year":"2015","journal-title":"J Rheumatol"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejim.2013.11.011","article-title":"Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.","volume":"25","author":"de Joode","year":"2014","journal-title":"Eur J Intern Med"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/ard.52.2.115","article-title":"Occurrence of autoantibodies to human leucocyte elastase in Wegeners granulomatosis and other inflammatory disorders.","volume":"52","author":"Tervaert","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","article-title":"Key advances in the clinical approach to ANCA-associated vasculitis.","volume":"10","author":"Kallenberg","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"3rd, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2011090920","article-title":"High prevalence of autoantibodies to hLAMP-2 in antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"23","author":"Kain","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2011030273","article-title":"Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis.","volume":"123","author":"Roth","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"643e9","DOI":"10.1016\/j.amjmed.2006.08.016","article-title":"ANCA are detectable in nearly all patients with active severe Wegeners granulomatosis.","volume":"120","author":"Finkielman","year":"2007","journal-title":"Am J Med"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis.","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/ndt\/gfh830","article-title":"ANCA-negative pauci-immune renal vasculitis: histology and outcome.","volume":"20","author":"Eisenberger","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2009.67","article-title":"ANCA-negative pauci-immune crescentic glomerulonephritis.","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000431336","article-title":"Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.","volume":"41","author":"Shah","year":"2015","journal-title":"Am J Nephrol"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1681\/ASN.2013030320","article-title":"Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN.","volume":"25","author":"Peschel","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort.","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg Strauss syndrome.","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2265.2001.01282.x","article-title":"Frequency of appearance of MPO-ANCA in Graves disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.","volume":"54","author":"Noh","year":"2001","journal-title":"Clin Endocrinol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/BOR.0b013e32835b4449","article-title":"Rheumatic manifestations of cocaine use.","volume":"25","author":"Graf","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4193\/Rhin13.112","article-title":"Cocaine-induced midline destructive lesions.","volume":"52","author":"Trimarchi","year":"2014","journal-title":"Rhinology"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"e89777","DOI":"10.1371\/journal.pone.0089777","article-title":"Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review.","volume":"9","author":"Ying","year":"2014","journal-title":"PLoS One"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.38389","article-title":"Brief report : prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.","volume":"66","author":"Mahr","year":"2014","journal-title":"Arthritis Rheum"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ki.2014.424","article-title":"Update on endocarditis-associated glomerulonephritis.","volume":"87","author":"Boils","year":"2015","journal-title":"Kidney Int"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"e112877","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS One"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RHU.0b013e31826d2005","article-title":"Proteinase-3 antineutrophil cytoplasmic antibody positivity in patients without primary systemic vasculitis.","volume":"18","author":"McAdoo","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegeners granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase-3 antineutrophil cytoplasmic antibodies and disease activity in Wegeners granulomatosis.","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis: a meta-analysis.","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R44-4-20210128","first-page":"231","article-title":"Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis Curr Opin R","volume":"27","author":"Fussner","year":"2015","journal-title":"heumatol"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis.","volume":"3","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficay of remission-induction regimens for ANCA-associated vasculitis.","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/art.38044","article-title":"Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"65","author":"Miloslavsky","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegeners): ten-year experience at a single center.","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegeners granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.","volume":"336","author":"Tervaert","year":"1990","journal-title":"Lancet"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titres: useful tool for prevention of relapses in ANCA-associated vasculitis.","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:27Z","timestamp":1620948867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201601000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000233","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}